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Abstract
Wharton’s jelly-derived Mesenchymal Stem Cells (MSCs) isolated from newborns with
intrauterine fetal growth restriction were previously shown to exert anabolic features includ-
ing insulin hypersensitivity. Here, we extend these observations and demonstrate that
MSCs from small for gestational age (SGA) individuals have decreased mitochondrial oxy-
gen consumption rates. Comparing normally grown and SGA MSCs using next generation
sequencing studies, we measured global transcriptomic and epigenetic profiles and identi-
fied E2F1 as an over-expressed transcription factor regulating oxidative metabolism in the
SGA group. We further show that E2F1 regulates the differential transcriptome found in
SGA derived MSCs and is associated with the activating histone marks H3K27ac and
H3K4me3. One of the key genes regulated by E2F1 was found to be the fatty acid elon-
gase ELOVL2, a gene involved in the endogenous synthesis of docosahexaenoic acid
(DHA). Finally, we shed light on how the E2F1-ELOVL2 pathway may alter oxidative respi-
ration in the SGA condition by contributing to the maintenance of cellular metabolic
homeostasis.
Introduction
There is a developmental component to the origin of metabolic diseases such as obesity, type 2
diabetes mellitus, and cardiovascular disease. Early studies focused on fetal growth impairment
as a risk factor for later disease [1, 2]. Whereas suboptimal prenatal nutrient supply and placen-
tal dysfunction can impair fetal growth, the long-term effects of early experience that increase
an individual’s metabolic risk are thought to be dependent on altered epigenetic regulation of
gene expression established within a critical window of fetal development [3–5].
PLOSONE | DOI:10.1371/journal.pone.0163035 September 15, 2016 1 / 23
a11111
OPEN ACCESS
Citation: Tan PY, Chang CW, Duan K, Poidinger M,
Ng KL, Chong YS, et al. (2016) E2F1 Orchestrates
Transcriptomics and Oxidative Metabolism in
Wharton’s Jelly-Derived Mesenchymal Stem Cells
from Growth-Restricted Infants. PLoS ONE 11(9):
e0163035. doi:10.1371/journal.pone.0163035
Editor: Jun Sun, University of Illinois at Chicago,
UNITED STATES
Received: May 26, 2016
Accepted: September 1, 2016
Published: September 15, 2016
Copyright: © 2016 Tan et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
All library data were deposited into the GEO
repository (GEO # GSE77260).
Funding: This research is supported by the
Singapore National Research Foundation under its
Translational and Clinical Research (TCR) Flagship
Programme and administered by the Singapore
Ministry of Health’s National Medical Research
Council (NMRC; www.nmrc.gov.sg), Singapore-
NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/
2014. SICS Investigators are supported through
To provide insights into future onset of metabolic disease, we used humanWharton’s jelly-
derived MSCs which are more primitive than MSCs derived from other sources [6] and retain
the potential to differentiate into multiple lineages. As these MSCs originate from the umbilical
cord, cellular changes in gene transcription and epigenetics may be passed onto the fetus, and
thus, predispose it to later health risk. Our laboratory has shown that such MSCs of growth
restricted neonates are hyper-anabolic with enhanced insulin sensitivity [7], reflecting the clini-
cal situation of growth restricted infants who are often insulin hypersensitive [8], but become
insulin resistant later in childhood [9]. The insulin-sensitive nature of MSCs derived from new-
borns with SGA was maintained when they were differentiated in vitro into mature adipocytes
[10]. However, little is known about the mechanisms controlling the increased insulin sensitiv-
ity of SGA newborns and whether the SGA associated gene expression pattern is preserved in
primary cells taken from SGA individuals.
Our goal is to understand the molecular basis of the altered metabolic state accompanying
the insulin hypersensitivity found in growth restricted infants which is eventually replaced by
insulin resistance in later childhood. There are close relationships between cellular energy
expenditure, nutrient uptake and insulin sensitivity. Previous work has suggested that develop-
mental programming is associated with changed mitochondrial function. For instance, fasting
adult subjects with prior SGA condition were shown to have a decreased energy expenditure
compared to a control group [11]. Resting energy expenditure was also reported to be lower in
children with term SGA background [12], as well as in rodent studies demonstrating reduced
cardiac muscle respiration in offspring from undernourished mothers [13].
In this study, we report the genome-wide transcriptomic and epigenomic studies utilizing
MSCs from SGA and normally grown appropriate for gestational age (AGA) infants with the
objective of identifying molecular signatures which may contribute to future metabolic risk in
the former but not the latter group. To minimize molecular changes due to in vitro culture
expansion, we worked with MSCs below passage 10. Our results show that MSCs taken from
SGA newborns are programmed for rapid cell proliferation with concomitant decrease in the
oxygen consumption rate (OCR). One key transcription factor highly expressed in the SGA-
derived MSCs was found to be E2F1. This transcription factor not only suppresses OCR, but
also regulates the transcript levels of a large fraction of differentially expressed genes (DEGs) in
the SGA group. Amongst those, we identified ELOVL fatty acid elongase 2 (ELOVL2), which is
involved in the metabolism of polyunsaturated fatty acids (PUFAs) and regulation of cellular
respiratory capability possibly via docosahexaenoic acid (DHA) [14, 15].
Materials and Methods
Clinical populations and sample collection
Fresh umbilical cords were obtained from children born at the National University Hospital
(NUH), Singapore. Prior written parental consent to participate in this study was obtained and
ethical approval obtained by the Domain Specific Review Board (DSRB, # 2011/00355) of
NUH.
Assessment of fetal growth characteristics
Methods for the assessment of fetal growth in this study have been published [7, 10]. In short,
SGA fetuses were identified via ultrasonographic parameters and defined as growing below the
10th percentile when compared to a control reference population. Standard scans were con-
ducted by trained ultrasonographers, using ultrasound machines (Aloka SSD- 4000, GE Volu-
son E8).
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Preparation and propagation of Mesenchymal Stem Cells (MSCs) from
human umbilical cord Wharton’s jelly
The preparation, full characterization, nomenclature and growth conditions of the primary
Mesenchymal Stem Cell (MSC) isolates used in this study have been reported [10]. WJ-MSCs
from 9 SGA individuals were subsequently referred to as MSC-01, MSC-56, MSC-70, MSC-75,
MSC-82, MSC-83, MSC-84, MSC-85 and MSC-86 while those from 5 AGA individuals as
MSC-31, MSC-44, MSC-50, MSC-57 and MSC-60.
Oxygen consumption rate (OCR)
Approximately 40,000 WJ-MSCs were seeded into each well of the XF24 Cell Culture Micro-
plate (Seahorse Bioscience, 100777–004) overnight. A XFe24 Extracellular Flux Analyzer (Sea-
horse Bioscience) was used to measure the oxygen consumption rate (OCR). Prior to each
assay run, cells were washed with XF Assay MediumModified DMEM (Seahorse Bioscience,
102365–100) which was supplemented with 2 mM sodium pyruvate and 25 mM glucose and
adjusted to pH 7.4. Drug compounds from the XF Cell Mito Stress Test Kit (Seahorse Biosci-
ence, 101706–100) were then injected sequentially into each well in the following order with
the final concentration in parentheses: Oligomycin (1 μM), FCCP (0.6 μM), followed by Anti-
mycin A (1 μM) with Rotenone (1 μM). OCR was measured three times before and after each
injection. Cells were harvested at the end of each run and protein concentration was deter-
mined using the Bradford assay (Biorad, 500–0205) for normalization across all wells.
BrdU incorporation assay
WJ-MSCs were first cultured in normal growth media then starved in growth media containing
only 1% fetal bovine serum for 24 hrs to synchronize cell growth. Following starvation, the
cells were labeled with 5-bromo-2'-deoxyuridine (BrdU) using the FITC BrdU Flow Kit (BD
PharmingenTM, 559619) for another 24 hrs before harvesting, fixing and staining according to
the manufacturer’s protocol. The flow cytometric samples were analyzed using the FACS-
Canto™ and the FACSDiva software (BD Biosciences).
Transient transfection
For short interfering RNA (siRNA) studies, WJ-MSC lines were transfected with 100nM
siRNA (Dharmacon ON-TARGETplus SMARTpool) twice at 24h intervals, using Lipofecta-
mine™ RNAiMAX Transfection Reagent (Invitrogen, 13778150) according to the manufactur-
er’s protocol. The siRNA sequences are listed in S1 Table. For overexpression studies, cells
were transfected with 10 μg of DDK-tagged plasmid DNA from Origene (pCMV6 empty vec-
tor, PS100001 or pCMV6-ELOVL2, RC209232) using Lipofectamine1 LTX with Plus™
Reagent (Invitrogen, 15338100) according to the manufacturer’s protocol. Cells were harvested
or assessed in downstream assays after 48 hrs from the second round of siRNA transfection or
after 72 hrs from plasmid overexpression.
SDS-PAGE and western blotting
Cells were lysed and protein concentration was determined using the Bradford reagent. PVDF
membrane was probed with primary and secondary antibodies before developing using the
ECL Plus Western Blotting Substrate (Pierce, 32132). Antibodies used are as follows: anti-E2F1
(Santa Cruz, sc-193X), anti-DDK (Origene, TA50011), anti-βactin (Sigma, A1978), ECL anti-
rabbit IgG HRP linked whole antibody (from donkey) (Amersham, NA934V) and anti-mouse
IgG HRP linked whole antibody (from sheep) (Amersham, NA931V).
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DHA treatment
WJ-MSCs were incubated with different concentrations of DHA (Sigma, D2534) before RNA
isolation or measurement of mitochondrial OCR.
MitoCarta2.0 Inventory
A comprehensive database, MitoCarta2.0 [16] comprising 1158 human mitochondrial genes,
was used to identify DEGs which may be potentially involved in mitochondrial respiration
pathways.
Statistics
Data are generally presented as means ± S.E.M. from independent biological experiments. All
comparisons between groups were assessed using a Student’s unpaired t-test unless otherwise
stated, with p-value< 0.05 generally being considered as significant.
RNA extraction and quantitative reverse transcription PCR (RT-qPCR)
Total cellular RNA fromWJ-MSCs was extracted using TRIzol1 Reagent (Invitrogen, 15 596–
026) and chloroform before purification with miRNeasy Mini Kit (Qiagen, 217004) according
to the manufacturer’s instructions. RNA integrity was checked and the concentration was
determined. 1 μg RNA was reverse transcribed using a High Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems, Inc., 4368813) and cDNA produced was subjected to real-
time RT-qPCR using the Power SYBR1 Green PCRMaster Mix (Applied Biosystems, Inc.,
4367659). Real-time RT-qPCR primer sequences are listed in S1 Table.
Whole transcriptome RNA-sequencing (RNA-seq)
2 μg of total cellular RNA was depleted of ribosomal RNA [rRNA] using the Ribo-Zero™Mag-
netic Gold Kit (Epicentre, MRZG126) as per manufacturer’s instructions. The removal effi-
ciency was confirmed using RNA 6000 Pico Kit (Agilent Technologies, 5067–1513). Libraries
were then constructed using the TruSeq Stranded Total RNA LT Kit A (Illumina, RS-122-
2201) according to the manufacturer’s protocol. Adapter-ligated cDNA was amplified with 10
cycles using the PCR Primer Cocktail and PCRMaster Mix provided. cDNA libraries were
checked for quality and quantified using the DNA 1000 Kit. The basal and E2F1 knockdown
RNA-seq libraries were sent to the Genome Institute of Singapore (GIS, Singapore) and the
Beijing Genomics Institute (BGI, China), respectively, for sequencing as 76-bp paired-end
reads on the Illumina HiSeq 2000 according to standard manufacturer’s procedures. Only
WJ-MSCs fromMSC-01, MSC-56, MSC-75, MSC-44, MSC-57 and MSC-60 were used for the
RNA-seq library preparation.
RNA-seq mapping, quantification and data analyses
Fastq files of RNA-seq were transferred into the Partek Genomic Suites (PGS, Partek). Reads
were trimmed and filtered based on quality scores and mapped to Human Genome Build
Hg19. Mapped reads were then quantified using GENCODE V19 transcriptome annotations.
Using "read count by gene level" file output from PGS, genes with low counts were removed
and only genes with more than 1 count per million (cpm) in at least three out of six samples
were considered for subsequent analyses.
To identify DEGs between the basal RNA-seq from SGA (MSC-01, MSC-56, and MSC-75)
and AGA (MSC-44, MSC-57 and MSC-60) groups, we performed differential analyses using
the EdgeR R package according to the recommendation in the EdgeR vignette. A fold change
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cutoff of 1.3 and a p-value cutoff of 0.05 were applied. To identify genes whose expression was
affected by E2F1 knockdown, we performed paired sample differential expression analysis on
the E2F1 knockdown RNA-seq data using EdgeR following the recommendation in the EdgeR
vignette. A fold change cutoff of 1.3 and a Benjamini Hochberg FDR cutoff of 0.05 were used.
Chromatin immunoprecipitation (ChIP)
Cells were cross-linked with 1% formaldehyde before sonicating in SDS lysis buffer using the
Diagenode Bioruptor. Fragmented chromatin was first pre-cleared with protein A-Sepharose
4B and rabbit IgG for 2 hrs before immunoprecipitating with fresh protein A-Sepharose 4B
and antibody at 4°C overnight. Sepharose beads were washed as described previously [10]
before eluting with 1% SDS followed by reverse cross-linking at 65°C overnight. Samples were
finally purified using the QIAquick PCR Purification kit (Qiagen, 28106) according to the
manufacturer’s protocol. Antibodies used include anti-E2F1 (Santa Cruz, sc-193X), normal
rabbit IgG (Santa Cruz, sc-2027), anti-H3K27ac (Abcam, ab4729), anti-H3K4me1 (Abcam,
ab8895), anti-H3K4me3 (Abcam, ab8580), anti-H3K36me3 (Abcam, ab9050) and anti-
H3K27me3 (Millipore, 07–449).
ChIP-sequencing (ChIP-seq)
ChIP-enriched DNA was first quantified with the Quant-iT™ PicoGreen1 dsDNA Assay Kit
(Invitrogen, P11496) and libraries were prepared from 5 ng of ChIP DNA using the TruSeq
ChIP Sample Preparation Kit Set A (Illumina, IP-202-1012) according to the manufacturer’s
protocol with slight modifications. Adapter-ligated DNA was amplified with 13 cycles using
the Primer Cocktail and Master Mix provided. Amplified products of appropriate sizes were
excised from agarose gel and purified using the MinElute Gel Extraction Kit (Qiagen, 28604).
DNA libraries were then checked for quality and quantified using the DNA 1000 Kit (Agilent
Technologies, 5067–1504). The histone modification and E2F1 ChIP-seq libraries were
sequenced by the Genome Institute of Singapore (GIS, Singapore) and the Beijing Genomics
Institute (BGI, China), respectively. All libraries were sequenced as 36-bp single-end reads
using the Illumina HiSeq 2000 according to standard manufacturer’s procedures. Only
WJ-MSCs fromMSC-01, MSC-56, MSC-75, MSC-44, MSC-57 and MSC-60 were used for the
ChIP-seq library preparation.
ChIP-seq mapping, peak calling and data analyses
All ChIP-seq data sets were aligned to Hg19 using Bowtie 1.1.0 [17]. We used MACS2 version
2.1.0.20150420 [18] to identify regions of ChIP-seq enrichment. BigWig tracks were generated
from all libraries after normalizing to genomic input using BamCompare [19] with Signal
Extraction Scaling (SES). The highest point in the track, within ±2 kb of the TSS, was then
recorded as the score of E2F1 or histone mark for the corresponding gene. The score was fur-
ther aggregated by group mean (SGA and AGA). For more accurate group comparisons, a scal-
ing factor was determined and multiplied with the ChIP-seq read scores from libraries of the
AGA-derived MSCs in order to minimize global bias with respect to all genes.
ChIP-seq binding strength was categorized according to the mean of ChIP-seq read score
across all six cell lines and is as follows: low or no binding (score< 2), moderate binding
(2 score 4) and high binding (score> 4). Tracks generated by BamCompare were
uploaded to the WashU browser [20] for ChIP-seq binding intensity visualization.
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De novo motif analysis using HOMER
We overlapped E2F1 peaks identified by MACS in all six cell lines and discarded peaks which
occurred in fewer than two cell lines. Next, we queried the intensity at the peak regions using
BigWig generated by BamCompare to obtain the top 500 most enriched peaks. De novo motif
analysis was then performed using HOMER (Hypergeometric Optimization of Motif EnRich-
ment) [21].
Transcription factor family motif enrichment using HOMER
We downloaded motif positions of transcription factors pre-scanned by HOMER [21] from
http://bit.ly/1MYXDDJ. Using Fisher’s Exact Test, we screened for motifs which are differen-
tially enriched between promoters of DEGs that are upregulated in AGA-derived MSCs and
those upregulated in SGA-derived MSCs. A positive set consists of genes containing motif
within ±2 kb of the TSS. To correct for multiple-testing for families with various motifs, we
performed Bonferonni correction by multiplying the best p-value within the family with the
number of motifs in the respective family, or alternatively, by using the median p-value, which-
ever is lesser to ensure fairness in ranking. Next, we performed another round of correction for
each family by computing FDR using the Benjamini Hochberg procedure.
Association of DEG and E2F1 binding sites from ENCODE
We downloaded the E2F1 binding sites in HeLa-S3 and MCF-7 cell lines from ENCODE. We
then performed Fisher's Exact Test to determine the extent of preferential E2F1 binding within
±2 kb of the TSS between DEGs up- and downregulated in SGA-derived MSCs.
Gene Ontology analysis
DEGs between SGA and AGA groups from the basal RNA-seq expression datasets were loaded
into the MetaCore portal (GeneGO, a Thomson Reuters business) to identify for enriched cel-
lular processes.
Accession number
All library data were deposited into the GEO repository (GEO # GSE77260).
Results
Phenotypic and transcriptomic differences between SGA- and AGA-
derived MSCs
Multipotent WJ-MSCs have the ability to differentiate into multiple lineages which are highly
relevant to the development of metabolic diseases. Molecular signatures favoring poor health
outcomes may be determined prenatally in SGA babies upon unfavorable perinatal insults [5,
22], making the readily obtainable WJ-MSCs a valuable model in studying potential biomark-
ers impacting future health status. We first assessed whether there were phenotypic differences
in key metabolic cellular measures such as mitochondrial oxygen consumption rates (OCR)
between MSC lines from 9 SGA and 5 AGA neonates. Our results show that SGA-derived
MSCs generally have a significantly lower OCR readout compared to their AGA counterparts
(Fig 1A), indicative of differences in energy metabolism. In an attempt to identify gene expres-
sion differences that might explain this finding, we performed RNA-seq on 6 representative
MSC lines under normal growing cell culture conditions. Overall, we found 388 genes that
were differentially expressed between the SGA and AGA groups, with 180 upregulated genes
E2F1 and Transcriptomics of Growth-Restricted Newborns
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Fig 1. Mitochondrial oxygen consumption is repressed and cell cycle gene expression is increased in MSCs
isolated from SGA newborns. (A) Basal and drug-stimulated mitochondrial oxygen consumption rates (OCR) between 9
SGA and 5 AGA lines as measured by the Seahorse XF analyser. Drugs which affect cell respiration were added in the
following order: Oligomycin (ATP synthase inhibitor), FCCP (uncoupler), followed by Rotenone and Antimycin A
(inhibitors of respiratory complexes I and III respectively). Top: Closed and open circles represent the OCR traces as
E2F1 and Transcriptomics of Growth-Restricted Newborns
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and 208 downregulated genes in the former group (Fig 1B). 28 of these differentially expressed
genes (DEGs) were randomly selected for validation using RT-qPCR, where we observed a
good correlation between the expression profiles from RNA-seq and RT-qPCR (S1 Fig). Path-
way analysis revealed that the DEGs identified are significantly overrepresented in cell cycle as
well as developmental processes (Fig 1C). The primary human MSC isolates established from
SGA neonates indeed possess a greater proportion of BrdU-stained cells (Fig 1D). This is in
concordance with an earlier study which reported that MSCs derived from growth restricted
neonates have increased cell proliferation rates [7], and enhanced proliferation growth is usu-
ally accompanied with metabolic changes [23].
E2F1 is overexpressed in MSCs isolated from SGA cells and alters the
mitochondrial oxygen consumption rate
Previous studies have highlighted the importance of cell cycle regulators in triggering an adap-
tive metabolic switch to meet higher energy demands [23]. Notably, E2F1, which is a well-char-
acterized ‘master regulator’ of cell cycle progression, was expressed at higher transcript (Figs
1B and 2A) and protein (Fig 2B) levels in SGA-derived MSCs when we examined a panel of 14
primary cell lines. E2F1 depletion induced by siRNA transfection led to increase in mitochon-
drial oxygen consumption (Fig 2C), and this is in agreement with our findings from basal
AGA-derived MSCs (Fig 1A) that have shown correspondingly lower expression of E2F1.
Given that E2F1 is pivotal in governing the expression of a wide repertoire of genes, we cou-
pled E2F1 knockdown with RNA-seq to determine its downstream targets. Overall, we found
846 repressed genes upon E2F1 depletion in SGA-derived MSCs, with 540 of them also being
down-regulated in AGA-derived MSCs (Fig 2D, top). We note that the highly efficient siE2F1
transfection condition (S2 fig) could have contributed to the huge disparity between the total
number of DEGs (Fig 1B) and E2F1-regulated genes (Fig 2D) as difference in E2F1 expression
between SGA and AGA-derived cells was approximately 2.8-fold while that before and after
siE2F1 introduction was greater than 5-fold. Reduced E2F1 expression also concomitantly
resulted in increased expression of 388 genes in both SGA and AGA-established MSCs (Fig
2D, bottom). Strikingly, we observed more than 35% of genes to be significantly affected by
siE2F1 in only one group of MSCs but not in the other (Fig 2D). For instance, siE2F1 resulted
in the repression of 306 out of 846 genes (36.2%) in SGA-derived MSCs, but not in the AGA-
derived counterparts, whereas 338 out of 878 genes had diminished expression levels selectively
in the latter group (38.5%, Fig 2D, top). In addition, we were able to identify 492 out of 880
genes (55.9%) and 272 out of 660 genes (41.2%) with elevated expression levels exclusively in
SGA- and AGA-derived MSCs, respectively. This prompted us to explore if E2F1 could have
disparate impact in regulating these genes between both groups of MSCs. To address this, we
plotted the E2F1 knockdown effects on all expressed genes in both types of MSCs and found
that there was a good correlation with r = 0.769 (Fig 2E). Hence, we conclude that the genes
expressed in pmol O2 per min normalized against protein amount upon drug treatments across time in SGA and AGA
lines, respectively. Bottom: Barchart indicating the OCRmeasurements in terms of pmol O2/min/μg protein for various
parameters. The data represent mean ± SEM of at least 3 independent experiments, * p < 0.05 where p-value was
calculated using an unpaired t-test. (B) Heatmap illustrating basal whole transcriptomic RNA-seq expression differences
of coding transcripts between 3 representative pairs of SGA (MSC-01, MSC-56 and MSC-75) and AGA lines (MSC-44,
MSC-57 and MSC-60). Yellow and blue bars represent up- and downregulation of gene expression between SGA and
AGA groups respectively ( 1.3-fold, p < 0.05). The red asterisk indicates the expression of E2F1 transcripts across all
cell lines. (C) Metacore GO of DEGs between SGA and AGA lines obtained from basal RNA-seq. Table shows the top ten
biological processes ranked by FDR. (D) Bars showing the fold difference of BrdU-stained cells for 9 SGA lines relative to
5 AGA lines. Results are represented as the mean ± SEM of at least 3 independent experiments, * p < 0.05 where p-value
was calculated using an unpaired t-test.
doi:10.1371/journal.pone.0163035.g001
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Fig 2. E2F1 is over-expressed inWharton’s jelly MSCs from SGA background. (A) Boxplot illustrating the relative E2F1 gene
expression in 9 SGA and 5 AGA lines. Total mRNA expression was quantified by real-time RT-qPCR. E2F1 expression levels were
normalized against those of β-actin. The data represent mean ± SEM of at least 3 independent experiments. The p-value was calculated
using an unpaired t-test. (B) E2F1 and β-actin protein expression levels in 9 SGA- and 5 AGA-isolated MSCs. (C) Basal and drug-induced
mitochondrial OCR in the MSCs was measured after transient transfection. Solid and dotted lines refer to the OCR traces before and after
E2F1 and Transcriptomics of Growth-Restricted Newborns
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affected by siE2F1 earlier appeared to be unique to one group (Fig 2D) due to the stringent sta-
tistical cut-off used for knockdown analyses. To further identify direct E2F1 gene targets, we
generated E2F1 ChIP-seq libraries to uncover genome-wide locations of E2F1 occupancy in
our primary MSC isolates. Previous studies carried out in other cell lines have shown that E2F1
is typically located within the gene promoter regions [24, 25]. Similarly, we also found predom-
inant recruitment of E2F1 (> 70% of E2F1 binding) to gene promoters (S3A Fig) with E2F1
mainly residing around the gene TSS (S3B Fig). By associating E2F1 binding with siE2F1
RNA-seq datasets, we found that even though E2F1 possesses a dual regulatory role, it acts
more as a transcriptional activator than repressor (Fig 2F).
Significant E2F1 enrichment at DEGs with enhanced expression in SGA
From our transcriptomic analyses, we noticed that the expression of approximately 50% of
DEGs was significantly affected by E2F1 down-regulation. Since E2F1 expression was found to
be substantially higher in SGA-established MSCs, we then asked whether the difference in
E2F1 levels could contribute to the observed DEG expression pattern. We compared the basal
and E2F1 depletion expression profiles and found that a significant proportion of DEGs that
are upregulated in the SGA-derived MSCs were down-regulated in the presence of siE2F1 (Fig
3A, p = 1.31 X 10−34). Conversely, DEGs which are down-regulated in the SGA-derived MSCs
tended to have elevated expression upon E2F1 knockdown (p = 1.44 X 10−31). This, again, sup-
ports the binary transcriptional role of E2F1 in MSCs fromWharton’s jelly and strongly sug-
gests that E2F1 is driving a significant proportion of the DEG expression.
To further dissect the importance of E2F1’s transcriptional activity, we segregated the E2F1
ChIP-seq sites into high, medium and low or negligible binding intensity and associated them
with the gene expression profiles. The number of genes for each category is listed in the S4 Fig.
As shown in Fig 3B, a large proportion of genes (65%) with higher basal expression in SGA-
derived MSCs exert medium to high E2F1 binding strength compared to only 30% for those
with lower basal expression (p<0.001, Fisher’s Exact Test). In addition, we also observed a
larger percentage of E2F1-activated genes (69%) with stronger E2F1 recruitment compared to
E2F1-repressed genes (47%, (p<0.001, Fisher’s Exact Test). Interestingly, upon integrating all
genomic datasets, we found further enrichment of E2F1 at E2F1-activated genes that are simul-
taneously expressed at higher amounts in the SGA-established MSC lines. Approximately 81%
of such genes are at least moderately occupied by E2F1.
Active histone H3K27ac and H3K4me3 marks are enriched at genes
upregulated in SGA-derived MSCs
Appropriate temporal and spatial recruitment of transcription factors and chromatin modifiers
is necessary for precise modulation of gene expression. To date, several predictive models have
been constructed to examine the intricate relationship between transcription factor binding,
histone modifications and mRNA abundance [26, 27]. In general, among the DEGs identified,
E2F1 depletion, respectively in the 6 representative MSC lines (MSC-01, MSC-56, MSC-75, MSC-44, MSC-57 and MSC-60). Results
represent mean ± SEM of at least 3 independent experiments. (D) Venn diagrams depicting the number of genes affected by E2F1
depletion, either unique to or common between SGA and AGA groups. Top and bottom panels show down- and upregulated genes upon
siE2F1 treatment from RNA-seq, respectively. (E) Scatterplot correlating gene expression upon E2F1 suppression in SGA and AGA lines.
Dotted lines indicate the log2-fold change of 0.38 approximately for both axes. Blue, red and green dots represent genes which were
significantly affected in the presence of E2F1 knockdown in SGA only, AGA only and both groups, respectively. Black dots represent the
remaining genes expressed in the transfected cell lines. Linear relationship was determined by a Pearson correlation coefficient (R). (F)
Barcharts showing the proportion of E2F1 up- (top) and downregulated (bottom) genes which are occupied by E2F1 at gene TSS
exclusively in SGA or AGA-derived MSCs or in both groups of cell lines.
doi:10.1371/journal.pone.0163035.g002
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Fig 3. E2F1 directly regulates DEGs overexpressed in SGA-derived MSCs. (A) Scatterplot illustrates log2-fold change
of basal gene expression between 3 SGA and 3 AGA lines against log2-fold change of gene expression upon siE2F1
treatment in the same MSC lines. Dotted lines indicate the log2-fold change of 0.38 approximately for both axes. Each blue
dot represents a gene which was identified as being both a DEG and a E2F1 target gene (p-values met) whereas the grey
dots represent the remaining genes expressed in the MSCs (most of which did not pass the p-value cutoff). Fisher’s exact
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we noticed there was minimal E2F1 binding at genes that are upregulated in the AGA-derived
MSCs (Fig 4A, left). However at the TSS of genes that are upregulated in the SGA counterparts,
E2F1 exhibited either strong or weak binding which likely suggests direct or indirect occu-
pancy, respectively (Fig 4A, left). Besides their promoter containing consensus E2F1 motif (Fig
4A, middle) as found by de novo motif analysis of our E2F1 ChIP-seq libraries (S5 Fig), these
DEGs with higher E2F1 binding are also largely involved in cell cycle regulation (S6 Fig). We
further used HOMER to identify differentially enriched transcription factor family motifs
between the two groups of DEGs and found that the E2F family motif appeared as the most sig-
nificant hit (S7A Fig). In addition, by using publicly available E2F1 ChIP-seq data sets from the
ENCODE project, we also managed to show that E2F1 indeed binds to a greater proportion of
SGA-upregulated genes compared to AGA-upregulated genes (S7B Fig). These findings cor-
roborated our hypothesis that E2F1 plays a predominant role at DEGs with enhanced expres-
sion in SGA-derived MSCs. Since E2F1 also mediates phenotypic changes in MSCs, this
prompted us to further investigate the direct transcriptional impact of E2F1 on the set of genes
with higher basal expression in SGA-established MSCs.
At the promoter of SGA-upregulated genes, we found no significant difference in E2F1
binding between SGA and AGA-derived MSCs (Fig 4B and 4C), suggesting that the differential
gene expression pattern observed was unlikely due to unequal E2F1 occupancy. However, from
the study of the ChIP-seq of active and repressive histone marks, we noticed differential
H3K27ac and H3K4me3 modifications at these genes (Fig 4B and 4C). The ChIP-seq intensi-
ties of H3K27ac and H3K4me3, which are both active histone marks, were significantly higher
(p< 0.001) in the SGA-derived MSCs compared to the AGA counterparts and this is in accord
with the observation that these genes were also expressed to a greater extent in the SGA-
derived MSCs. In contrast, genes which were downregulated in SGA-derived MSCs had similar
E2F1, H3K27ac and H3K4me3 levels generally (Fig 4C). By further splitting the SGA-upregu-
lated genes into E2F1-bound and -unbound, we observed that only genes occupied by E2F1 at
the promoter have correspondingly higher H3K27ac and H3K4me3 modifications in SGA-
derived MSCs compared to AGA counterparts (S8 Fig). All in all, we postulate that E2F1
recruitment is potentially important in priming the promoter of SGA-upregulated genes for
specific histone modifications (H3K27ac and H3K4me3).
ELOVL2 is a novel E2F1-activated gene upregulated in SGA-derived
MSCs and associated with histone H3K27ac and H3K4me3 marks
Next, we then sought to identify and characterize genes with important metabolic functions,
whose expression is modulated by E2F1 transcriptional activity. From our E2F1 knockdown
RNA-seq study, we identified ELOVL2 as a candidate gene. By performing RT-qPCR in 14
MSC lines, we validated that the suppression of E2F1 expression significantly diminished the
ELOVL2 transcript level (Fig 5A). Our genome-wide expression profiling of umbilical cord-
derived MSCs also revealed that ELOVL2 was overexpressed in the SGA-isolated MSCs and we
further confirmed the disparate expression in more cell lines (n = 9 SGA, n = 5 AGA, Fig 5B).
However, as there is currently no good antibody available to enable ELOVL2 protein detection,
test was used to determine the significance for the number of genes (blue dots) in each quadrant and the p-values are
shown in parentheses. (B) Stacked barcharts showing the proportion of gencode V19 gene promoters with varying degrees
of E2F1 binding where green, red and blue bars represent high, moderate and low or negligible E2F1 binding, respectively.
Categories of “S > A”, “S < A”, “S = A” and “UN” represent DEGs with higher basal expression in SGA, DEGs with higher
basal expression in AGA, expressed genes excluding DEGs and unexpressed genes, respectively. Categories of “#”, “"”
and “-” represent genes whose expressions were downregulated, upregulated or remained unchanged upon siE2F1
treatment, respectively. The absolute number of genes in each subcategory is shown in S4 Fig.
doi:10.1371/journal.pone.0163035.g003
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Fig 4. Active H3K27ac and H3K4me3marks, but not E2F1, are enriched in SGA-derived MSCs at promoters of upregulated DEGs. (A)
Heatmaps illustrating E2F1 ChIP-seq binding (left), E2F1 de novo motif enrichment (middle) and siE2F1 RNA-seq gene expression modulations
(right) for all DEGs sorted according to the basal RNA-seq fold change expression difference between both groups of MSCs with SGA-upregulated
genes on top followed by AGA-upregulated genes below. For the motif enrichment heatmap, the color intensity corresponds to the highest scoring
motif within a 100bp window. For both binding and motif enrichments, signal intensities were plotted around the TSS ±5 kb of each DEG. (B)
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we could not validate the ELOVL2 overexpression at the protein level. The promoter of the
ELOVL2 gene was bound by E2F1 and associated with several histone marks such as H3K27ac,
H3K4me3 and H3K27me3 (Fig 5C). Interestingly, despite similar E2F1 occupancy, we
observed enhanced H3K27ac and H3K4me3 modifications in the SGA-derived MSCs with cor-
respondingly lesser H3K27me3 marks that may explain the elevated ELOVL2 expression in
these cells. As shown in Fig 5D, the loss of ELOVL2 resulted in significant increase in cellular
oxygen consumption and this resembles the results from the transient knockdown of E2F1 (Fig
2C). Taken together, our results suggest that ELOVL2 is a novel direct target of E2F1 and medi-
ates a metabolic switch via regulating mitochondrial respiration.
ELOVL2-regulation of mitochondrial genes via DHA
ELOVL2 is known for catalyzing the elongation of 22-carbon PUFAs to 24-carbon precursors
necessary for DHA formation. Upon increasing dosage of DHA, the MSC respiratory capacity
was significantly reduced (Fig 6A and S9A Fig) and this mirrors the effect of enhanced
ELOVL2 expression (Fig 6B and S9B Fig), suggesting that ELOVL2 may control cellular respi-
ration through the endogenous synthesis of DHA. In order to identify putative DEGs directly
involved in mitochondrial respiration pathways, we mined the extensively curated database,
MitoCarta2.0 [16]. We found 11 out of our previously identified DEGs within the database,
among which LYRM5 (LYR motif-containing protein 5) and MAOA (monoamine oxidase A)
gene expression increased upon DHA stimulation (S10 Fig). LYRM5 is required for the assem-
bly of the core oxidative phosphorylation complex I [28] and its expression change may per-
turb the mitochondrial redox balance. Increased MAOA expression induces oxidative stress,
damages the mitochondria and subdues respiration [29], which is also in line with our DHA-
treated metabolic data (Fig 6A and S9A Fig). Thus, our data suggest that E2F1 and ELOVL2
may systematically fine-tune the cellular respiration through mitochondrial-related genes such
as LYRM5 and MAOA.
Discussion
Factors present at various stages during the intrauterine development are able to induce
changes in fetal cells leading to changes in cellular metabolism. For example, prenatal maternal
protein restriction has been shown to induce rapid proliferation of rat offspring preadipocytes
[30] and our previous data from humanWarton’s jelly-derived MSCs showed differential basal
proliferation rates from SGA and AGA groups [7]. This increased potential for cellular prolif-
eration may play a role in the phase of rapid catch-up growth in infancy that follows growth
retardation and in the deposition of fat which has an important evolved role in protecting the
programmed infant from the effects of predicted malnutrition. Insulin hypersensitive growth-
restricted infants with prior exposure to lipid-rich breast milk would confer a switch to the pro-
tective state of insulin resistance once breast-feeding terminated and nutrition became more
uncertain [31]. Human infants are the fattest of all mammalian species at birth and it has been
suggested this is because of the high metabolic demands of the human brain and the adiposity
of growth restricted infants would have been a relative protection against nutritional compro-
mise at the time of weaning [32]. Rapidly dividing cells also utilize more glucose thereby
Boxplots comparing ChIP-seq intensities of E2F1 and five histone modifications (H3K27ac, H3K27me3, H3K4me1, H3K4me3 and H3K36me3) in
MSCs established from SGA and AGA neonates. The p-values were calculated using aWilcoxon’s test. (C) Scatterplots illustrating ChIP-seq
intensities of E2F1 (left), H3K27ac (middle) and H3K4me3 (right) between SGA and AGA-derived MSCs at both groups of DEGs. Top: DEGs with
higher basal gene expression in SGA-derived MSCs; bottom: DEGs with higher basal gene expression in AGA-derived MSCs. The p-values were
calculated using a two-tailed binomial test.
doi:10.1371/journal.pone.0163035.g004
E2F1 and Transcriptomics of Growth-Restricted Newborns
PLOS ONE | DOI:10.1371/journal.pone.0163035 September 15, 2016 14 / 23
Fig 5. E2F1 directly activates the expression of ELOVL2 which mediates mitochondrial respiration. (A) Paired dot
plot demonstrating the relative expression of ELOVL2 before and after E2F1 knockdown in 14 derived lines. Each dot
represents the normalized expression of ELOVL2 gene against that of the β-actin gene. Paired colored dots indicate
individual cell lines prior to and after E2F1 depletion. The data represent mean of at least 3 independent experiments. The
p-value was calculated using a paired t-test. (B) Boxplot showing the relative ELOVL2 mRNA expression in 9 SGA and 5
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AGA lines. Gene expression was measured by real-time RT-qPCR and ELOVL2 expression levels were normalized against
those of β-actin. The data represent mean ± SEM of at least 3 independent experiments. The p-value was calculated using
an unpaired t-test. (C) The screenshot shows genome browser tracks for ChIP-seq of H3K27me3, H3K4me1, H3K36me3,
H3K27ac, H3K4me3 and E2F1 (tracks in orange, dark blue, pink, magenta, green and light blue, respectively) around the
ELOVL2 gene in SGA- and AGA-derived MSCs. E2F1 motifs are marked by red and blue rectangular blocks indicating a
forward or reverse match with respect to the reference genome. Genes in the vicinity are indicated below the tracks. (D)
After siRNA transfection, mitochondrial OCR was measured in the absence and presence of drug stimulation in 6
representative MSC lines (MSC-01, MSC-56, MSC-75, MSC-44, MSC-57 and MSC-60). Red and blue lines refer to SGA-
and AGA-derived MSC groups, respectively, while solid and dotted lines refer to the OCR traces before and after ELOVL2
knockdown, respectively. Results represent mean ± SEM of at least 3 independent experiments.
doi:10.1371/journal.pone.0163035.g005
Fig 6. ELOVL2 controls cellular respiration possibly via DHA. (A) Upon treatment of increasing DHA concentration for 24 hrs,
mitochondrial OCR was measured in a representative AGA derived MSC line (MSC-60). Results represent mean ± SEM of at least 3
independent experiments. (B) Assessment of mitochondrial OCR in a representative AGA derived MSC line (MSC-60) before and after
ELOVL2 overexpression, respectively. Results represent mean ± SEM of at least 3 independent experiments. Top right: Representative
western blot image before and after ELOVL2 overexpression in MSCs.
doi:10.1371/journal.pone.0163035.g006
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increasing their glycolytic rate with concomitant decrease in mitochondrial oxidative phos-
phorylation [23]. This is reminiscent of the Warburg effect, which describes the utilization of
aerobic glycolysis in highly proliferative cancer cells [33, 34]. Our MSCs taken from the SGA
group of newborns show a similar metabolic profile, but Wharton’s jelly-derived MSCs are
generally not transformed and hence, it remains questionable what the molecular causes are
for the increased proliferation and decreased oxygen consumption rates of MSCs isolated from
growth-restricted individuals.
Our studies show that cell cycle related pathways were found to be enriched in the SGA
transcriptome with E2F1 being most prominent (Fig 1C) and that E2F1 depletion in WJ-MSCs
led to changes in mitochondrial oxidative respiration (Fig 2C). Cell cycle regulators including
E2F1 have previously been shown to regulate metabolism in cancer cells [23]. In particular,
E2F1 was reported to suppress oxidative metabolism by acting as a metabolic switch changing
from mitochondrial respiration to increased glycolysis [35]. One mechanism of how E2F1 can
enhance glycolysis is the suppression of the protein deacetylase enzyme SIRT6 in prostate- and
bladder cancer cells [36]. The same report revealed that E2F1 itself is under the regulation of
epigenetic modifiers such as HDAC1. In our study with non-transformed Wharton’s jelly-
derived MSCs, we triangulated RNA-seq expression with E2F1 siRNA knockdown and histone
ChIP-seq to identify novel gene candidates regulated by E2F1 and associated epigenetic path-
ways. We report that E2F1 is preferentially found at the promoter of SGA-upregulated genes
among the DEGs. However, interestingly, we did not observe any significant difference in the
E2F1 binding strengths between the SGA and AGA groups of MSC isolates despite the higher
expression levels of E2F1 and its dependent downstream gene targets in the SGA group.
Instead, we noticed enhanced activating histone marks, H3K27ac and H3K4me3, at these
SGA-upregulated genes in the SGA-isolated MSCs compared to their AGA counterparts (Fig
4C). Recently, a few groups have highlighted the predictive power of transcription factor bind-
ing profiles on histone modifications and subsequently targeted gene expression [37, 38], sug-
gesting the dependency of histone modifications on transcription factor recruitment to DNA
genomic regions. Herein, we postulate that E2F1 primes the promoter region of SGA-upregu-
lated genes for potential recruitment of epigenetic modifiers leading to altered H3K27ac and
H3K4me3 levels allowing gene activation (Fig 7), as we observed differential histone marks
only at the gene TSS with existing E2F1 binding (see S8 Fig). However, the selective spatial
recruitment of histone modifiers to these genes in the SGA but not in the AGA group of MSCs
still remains to be explored and we postulate that cofactors of E2F1 may play a role in mediat-
ing such specificity. More work involving histone deacetylase and demethylase pathways needs
to be conducted to further substantiate the direct epigenetic impact of H3K27ac and H3K4me3
marks on this group of associated DEGs. Notably, we also observed stronger H3K4me3 inten-
sity at the E2F1 promoter (see S11 Fig) and this may explain the substantial increase of E2F1
expression in SGA-derived MSCs (Figs 1B, 2A and 2B).
In addition to promotion of cell cycle progression, there may be biological consequences
arising from E2F1 overexpression in SGA newborns. Our findings suggest a novel pathway
showing that ELOVL2 is a gene directly regulated by E2F1 (Fig 5A) and overexpressed in the
SGA group of MSCs (Fig 5B). Depletion of ELOVL2 (Fig 5D) led to similar mitochondrial
OCR changes as siE2F1 (Fig 2C) and ELOVL2 overexpression was able to reverse the metabolic
phenotype (Fig 6B and S9B Fig). ELOVL2 is known to catalyze the endogenous elongation of
PUFAs with 22 carbons resulting in the formation of DHA [14, 15] which is necessary for nor-
mal fetal development [39]. The endogenous docosapentaenoic acid (DPA) to DHA conver-
sion step has been reported earlier to be compromised in infants with intrauterine growth
restriction [40]. In addition, the DHA deficit in growth restricted fetuses may also be a conse-
quence of maternal diets low in lipids [41]. Thus, the increased expression of ELOVL2 may
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seem to serve as a compensatory mechanism to supplement growth restricted infants with
DHA. However, since ELOVL2 knockout mice were found to be resistant to diet-induced
weight gain [15], enhancing ELOVL2 expression not only stimulates lipid synthesis but also
results in weight gain. Therefore, higher ELOVL2 expression may be a risk factor for the devel-
opment of obesity and associated co-morbidities for individuals with prior pre-natal SGA con-
dition. Nonetheless, more work has to be done to confirm the increase in DHA levels upon
ELOVL2 overexpression in our MSC lines.
Biomarker hypotheses for early detection of SGA have previously been made and were
related to aberrant expression and function of metabolic enzymes such as glycogen phosphory-
lase isoenzyme BB which was found to be increased in SGA pregnancies [42] or decreased irisin
levels in cord blood from SGA children [43]. The E2F1-ELOVL2-DHA axis discovered in our
study of Wharton’s jelly-derived MSCs taken from growth restricted newborns has not been
described before. Furthermore, our findings provided insights into the potential dynamics of
metabolic respiration by modulating the expression of crucial mitochondrial genes such as
LYRM5 and MAOA. It may constitute a novel pathway for targeted interventions at a very
early stage in life before the onset of overt metabolic disease.
Fig 7. Illustration depicting the E2F1-directed transcriptional regulation of DEGs whose expressions are elevated in MSCs isolated from SGA
neonates. Illustrations depicting the E2F1 directed transcriptional regulation of DEGs whose expressions are elevated in MSCs isolated from SGA
neonates. Left: In the SGA-derived MSCs, E2F1 activates ELOVL2 expression via an open chromatin structure harboring histone H3K27ac and
H3K4me3marks, and resulting in impaired mitochondrial oxygen usage which may contribute to the development of metabolic health compromise in later
life. Right: In AGA-derived MSCs, although E2F1 primes the promoter, epigenetic modulators are not recruited to activate the transcriptional machinery at
DEGs and, thus, mitochondrial homeostasis is unperturbed. RNAPII: RNA polymerase II; HAT: Histone acetyltransferase; HMT: Histone
methyltransferase; HDAC: Histone deacetylase; HDM: Histone demethylase.
doi:10.1371/journal.pone.0163035.g007
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Conclusions
We discovered ELOVL2 as a gene regulated by E2F1 in the context of fetal growth restriction.
Expression of both genes was found up-regulated in Wharton’s jelly derived MSCs taken from
SGA infants and we further demonstrated that both genes are associated with specific histone
marks promoting their expression. The E2F1-ELOVL2 pathway suppresses mitochondrial res-
piration which can be viewed as a hallmark of increased metabolic disease risk.
Supporting Information
S1 Fig. Gene expression validated by RT-qPCR correlates well with RNA-seq datasets. Scat-
terplot of expression level of 28 transcripts measured by RT-qPCR versus basal whole tran-
scriptomic RNA-seq in 6 representative MSC lines (MSC-01, MSC-56, MSC-75, MSC-44,
MSC-57 and MSC-60).
(TIF)
S2 Fig. E2F1 transient knockdown efficiency in MSCs. (A) Bars showing the knockdown effi-
ciency of siE2F1 when compared to siCTRL in 6 MSC lines (MSC-01, MSC-56, MSC-75, MSC-
44, MSC-57 and MSC-60). Total mRNA expression was quantified by real-time RT-qPCR.
E2F1 expression levels were normalized against those of β-actin before comparing siE2F1 con-
dition relative to that of siCTRL. The data represent mean ± SEM of at least 3 independent
experiments ( p<0.001). (B) E2F1 and β-actin protein expression levels after transfection of
siCTRL or siE2F1 in a representative MSC line, MSC-56.
(TIF)
S3 Fig. E2F1 binds predominantly at gene TSS in Wharton’s jelly MSCs. (A) Percentage of
E2F1 binding in 6 MSC lines at different genomic locations relative to nearest transcription
units from the gencode V19 database. (B) Distribution of E2F1 occupancy within 3 kb up- and
downstream of gene TSS.
(TIF)
S4 Fig. Tables showing the number of genes observed in different subcategories. (A) Num-
ber of genes with differential basal expression between the derived groups of cell lines and (B)
gene expression changes upon E2F1 knockdown (KD) or (C) both, with their respective E2F1
binding strength at the gene TSS. Categories of “S> A”, “S< A”, “S = A” and “UN” represent
DEGs with higher basal expression in SGA, DEGs with higher basal expression in AGA,
expressed genes excluding DEGs and unexpressed genes, respectively. Categories of “#”, “"”
and “-” represent genes whose expressions were downregulated, upregulated or remained
unchanged upon siE2F1 treatment, respectively. A p-value of<0.005 was obtained using the
Fisher’s Exact Test on the subcategory with the following combined attributes: basal expression
of “S> A”, KD of “#” and E2F1 binding of “Moderate” and “High”.
(TIF)
S5 Fig. De novo motif discovery by HOMER shows E2F1 as the most enriched transcription
factor motif in Wharton’s jelly MSCs. Top 500 binding sites from our E2F1 ChIP-seq libraries
were fed into HOMER for de novo motif discovery. The top panel shows the de novo motif
analysis output while the bottom panel shows one of the E2F1 motifs from HOMER’s known
motif database.
(TIF)
S6 Fig. Gene Ontology analyses for SGA-upregulated DEGs.Metacore GO of DEGs which
have higher basal expression in SGA compared to AGA-derived MSCs. Top and bottom tables
are GO results from DEGs with high and moderate fold change differences between SGA and
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AGA groups. Tables show the top ten biological processes ranked by FDR.
(TIF)
S7 Fig. Differential enrichment of E2F1 motif between SGA and AGA groups of cell lines
at promoters of DEGs with higher expression in SGA-derived MSCs. (A) Top 10 transcrip-
tion factor family motifs found by HOMER to be differentially enriched at promoters of DEGs
which are upregulated in SGA-isolated MSCs compared to promoters of DEGs which are upre-
gulated in AGA-isolated MSCs. (B) Vertical bar plot depicting the proportion of DEGs con-
taining E2F1 binding from multiple publicly available ChIP-seq data sets belonging to the
ENCODE project. S> A: DEGs with higher expression in SGA-derived MSCs; S< A: DEGs
with higher expression in AGA-derived MSCs. The p-value was calculated using a Fisher’s
Exact Test.
(TIF)
S8 Fig. Only E2F1-bound DEGs have significantly higher H3K27ac and H3K4me3 modifi-
cations in SGA-derived vs AGA-derived MSCs. Scatterplots illustrating ChIP-seq intensities
of H3K27ac (left) and H3K4me3 (right) between SGA and AGA-derived MSCs at SGA-upre-
gulated DEGs. Top: DEGs with E2F1 binding at the promoter; bottom: DEGs with negligible
E2F1 binding at the promoter. The p-values were calculated using a two-tailed binomial test.
(TIF)
S9 Fig. ELOVL2 controls cellular respiration possibly via DHA in additional AGA and
SGAMSC lines. (A) Upon treatment with increasing DHA concentration for 24 hrs, mito-
chondrial OCR was measured in 3 additional MSC lines (MSC-44, MSC-56 and MSC-70).
Results represent mean ± SEM of at least 3 independent experiments. (B) Assessment of mito-
chondrial OCR in 2 additional MSC lines (MSC-70 and MSC-56) before and after ELOVL2
overexpression, respectively. Results represent mean ± SEM of at least 3 independent experi-
ments.
(TIF)
S10 Fig. Elevated DHA levels lead to concentration-dependent increase in gene expression
of LYRM5 and MAOA which are important in maintaining the homeostasis of mitochon-
drial respiration. Relative expression levels of (A) LYRM5 and (B) MAOA in the presence of
DHA stimulation prior and after DHA treatment in 3 representative MSC lines. The data rep-
resent mean ± SEM of at least 3 independent experiments. Unpaired t-test was calculated
between 0 μM and 150 μMDHA treated conditions,  p< 0.05.
(TIF)
S11 Fig. ChIP-seq profiles of E2F1 and histone marks, as well as E2F1 motif in the vicinity
of the E2F1 gene. The screenshot shows the genome browser tracks for ChIP-seq of
H3K27me3, H3K4me1, H3K36me3, H3K27ac, H3K4me3 and E2F1 (tracks in orange, dark
blue, pink, magenta, green and light blue, respectively) around the E2F1 gene in SGA- and
AGA-derived MSCs. E2F1 motifs are marked by red and blue rectangular indicating forward
or reverse match with respect to the reference genome. Genes in the vicinity are indicated
below the tracks.
(TIF)
S1 Table. Sequences of gene-specific PCR primers and small interfering RNA oligonucleo-
tides.
(XLSX)
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